Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × acalabrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 53 Lymphoma, Mantle-Cell 31 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, Non-Hodgkin 14 Lymphoma 11 Leukemia, B-Cell 7 Lymphoma, Follicular 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, B-Cell 5 Leukemia 5 Waldenstrom Macroglobulinemia 4 Multiple Myeloma 3 Recurrence 2 Pancreatic Neoplasms 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Prolymphocytic 2 Hematologic Neoplasms 2 Cardiovascular Diseases 2 Squamous Cell Carcinoma of Head and Neck 1 Pyloric Stenosis, Hypertrophic 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Neuritis 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia, Hairy Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1

Interventions

pembrolizumab 90 Gemcitabine 55 Nivolumab 49 Cisplatin 38 atezolizumab 37 Carboplatin 30 avelumab 29 enfortumab vedotin 24 Docetaxel 23 Magnetic Resonance Spectroscopy 18 Ipilimumab 17 Paclitaxel 16 Mitomycin 16 Specimen Handling 13 durvalumab 11 toripalimab 10 sacituzumab govitecan 10 Pemetrexed 10 cabozantinib 9 Taxes 8 vinflunine 7 Cyclophosphamide 7 tislelizumab 6 Injections 6 Bevacizumab 6 pemigatinib 5 fludarabine 5 disitamab vedotin 5 Standard of Care 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351739 2019-09-10

KEYNOTE143

Acerta Pharma BV

Phase 2 Completed

78 enrolled 10 charts

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡